688163 賽倫生物
按盤價 
23.920 +0.560 (+2.397%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.783 | 4.061 | 3.513 | 8.610 | 23.029 |
| 總資產報酬率 ROA (%) | 5.629 | 3.940 | 3.379 | 8.181 | 21.393 |
| 投入資產回報率 ROIC (%) | 5.744 | 4.008 | 3.446 | 8.387 | 22.219 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.427 | 78.057 | 75.709 | 83.770 | 83.682 |
| 營業利潤率 (%) | 42.841 | 26.670 | 24.184 | 42.855 | 42.268 |
| 息稅前利潤/營業總收入 (%) | 41.910 | 25.084 | 22.672 | 40.964 | 41.803 |
| 淨利潤/營業總收入 (%) | 36.663 | 22.723 | 20.392 | 36.849 | 36.648 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.487 | 101.801 | 88.006 | 78.660 | 97.011 |
| 價值變動淨收益/利潤總額(%) | 10.263 | 10.223 | 22.756 | 21.667 | -0.896 |
| 營業外收支淨額/利潤總額(%) | -0.285 | -2.806 | -1.252 | -0.843 | -0.378 | 償債能力分析 |
| 流動比率 (X) | 28.716 | 46.700 | 37.979 | 37.104 | 14.050 |
| 速動比率 (X) | 27.503 | 44.495 | 36.188 | 35.075 | 11.263 |
| 資產負債率 (%) | 3.138 | 2.190 | 3.778 | 3.845 | 8.256 |
| 帶息債務/全部投入資本 (%) | 0.285 | 0.227 | 0.333 | 0.294 | 0.712 |
| 股東權益/帶息債務 (%) | 34,893.279 | 43,849.608 | 29,465.780 | 33,387.045 | 13,386.062 |
| 股東權益/負債合計 (%) | 3,086.373 | 4,465.353 | 2,547.012 | 2,500.496 | 1,111.266 |
| 利息保障倍數 (X) | -51.818 | -29.206 | -18.689 | -26.735 | -137.029 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 78.515 | 54.775 | 28.697 | 17.841 | 11.392 |
| 存貨周轉天數 (天) | 293.115 | 370.449 | 386.922 | 660.221 | 522.744 |
| 備註： | 即時報價更新時間為 13/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
